Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family

This study has been completed.
Sponsor:
Collaborator:
National Marrow Donor Program
Information provided by (Responsible Party):
Center for International Blood and Marrow Transplant Research
ClinicalTrials.gov Identifier:
NCT00795054
First received: November 19, 2008
Last updated: October 5, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2015
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)